The influence of blinding and un-blinding on statin related adverse events (AEs): new evidence from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
27 August 2016 (00:00 - 00:00)
Organised by:
About the speaker
Queen Mary University of London, London (United Kingdom of Great Britain & Northern Ireland)
5 More presentations in this session
Doctor A. Vallejo-Vaz (Seville, ES)
Professor A. Lincoff (Cleveland, US)
Professor A. Eisen (Petah Tikva, IL)
Professor P. Neuzil (Prague, CZ)
Professor E. Standl (Munich, DE)
Access the full session
The Event
ESC Congress 2016
27 August - 31 August 2016
